Olive Diagnostics secured a significant $1M grant investment from Maccabi Fund and Mekorot in January 2023. Overall, the company's innovative approach to continuous urinalysis presents a unique and promising opportunity in the healthcare industry, with the potential to revolutionize the way individuals manage and monitor their health.
General Information
BounceWatch is an independent company data service, not affiliated with Olive Diagnostics. To contact Olive Diagnostics, visit olive.earth.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Olive Diagnostics
Taxonomy: health monitoring, continuous urinalysis, biomarker analysis, medical device innovation, remote health monitoring, passive sensor technology, early disease detection, real-time health alerts, innovative diagnostics, urine analysis, optical sensor technology, self-monitoring devices, personal health tracking, innovative healthcare solutions
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $1.00M | 2 |
Maccabi Fund, Mekorot
|
09 Jan 2023 |
| Seed Round | $2.00M | 2 | 01 Jan 2023 | |
| Seed Round | $1.50M | 5 | 25 May 2022 | |
| Seed Round | $4.00M | 1 |
Maccabi Fund
|
24 Aug 2021 |
| Seed Round | $1.50M | - |
|
24 Nov 2019 |
Olive Diagnostics Alternatives & Competitors
View All AlternativesAI-powered Remote Cardiovascular Diagnostics
Experience effortless daily biomarker tracking with advanced self-testing capsules.
FAQ About Olive Diagnostics
Source: BounceWatch company record for Olive Diagnostics, https://bouncewatch.com/company/olive-diagnostics, updated 25 November 2024. When citing, please name BounceWatch and link this page.